ScholarIQanswers from OpenAlex

RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway

PaperCitations, authors & open-access status

RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway is a paper indexed in ScholarIQ from OpenAlex.

How many citations does RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway have?

ScholarIQcitation count

RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway has 66 citations in the OpenAlex counts ScholarIQ stores.

When was RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway published?

ScholarIQyear

RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway has 2020 year in the ScholarIQ index.

What is the open-access status of RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway?

ScholarIQoa status

RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway has gold oa status in the ScholarIQ index.

What is the DOI of RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway?

ScholarIQdoi

The DOI for RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway is on the source record.

What is the PMID of RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway?

ScholarIQpmid

The PMID for RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway is on the source record.

What is the OpenAlex record for RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway?

ScholarIQopenalex

The OpenAlex for RETRACTED: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial